AllianceBernstein’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.6K | Buy |
+15,200
| New | +$21.6K | ﹤0.01% | 3230 |
|
|
2024
Q2 | – | Sell |
-60,400
| Closed | -$74.9K | – | 3233 |
|
|
2024
Q1 | $74.9K | Hold |
60,400
| – | – | ﹤0.01% | 3055 |
|
|
2023
Q4 | $63.4K | Hold |
60,400
| – | – | ﹤0.01% | 3115 |
|
|
2023
Q3 | $414K | Hold |
60,400
| – | – | ﹤0.01% | 2657 |
|
|
2023
Q2 | $626K | Hold |
60,400
| – | – | ﹤0.01% | 2518 |
|
|
2023
Q1 | $489K | Hold |
60,400
| – | – | ﹤0.01% | 2585 |
|
|
2022
Q4 | $951K | Buy |
60,400
+14,300
| +31% | +$225K | ﹤0.01% | 2311 |
|
|
2022
Q3 | $726K | Hold |
46,100
| – | – | ﹤0.01% | 2456 |
|
|
2022
Q2 | $644K | Buy |
46,100
+4,300
| +10% | +$60.1K | ﹤0.01% | 2561 |
|
|
2022
Q1 | $721K | Buy |
41,800
+9,200
| +28% | +$159K | ﹤0.01% | 2527 |
|
|
2021
Q4 | $474K | Buy |
32,600
+4,800
| +17% | +$69.8K | ﹤0.01% | 2760 |
|
|
2021
Q3 | $500K | Hold |
27,800
| – | – | ﹤0.01% | 2746 |
|
|
2021
Q2 | $488K | Buy |
+27,800
| New | +$488K | ﹤0.01% | 2812 |
|
|
2020
Q2 | – | Sell |
-55,200
| Closed | -$57K | – | 3186 |
|
|
2020
Q1 | $57K | Hold |
55,200
| – | – | ﹤0.01% | 3031 |
|
|
2019
Q4 | $104K | Hold |
55,200
| – | – | ﹤0.01% | 3026 |
|
|
2019
Q3 | $60K | Hold |
55,200
| – | – | ﹤0.01% | 3107 |
|
|
2019
Q2 | $121K | Buy |
55,200
+7,700
| +16% | +$16.9K | ﹤0.01% | 3045 |
|
|
2019
Q1 | $285K | Buy |
47,500
+8,000
| +20% | +$48K | ﹤0.01% | 2775 |
|
|
2018
Q4 | $292K | Buy |
39,500
+8,600
| +28% | +$63.6K | ﹤0.01% | 2737 |
|
|
2018
Q3 | $449K | Buy |
30,900
+2,100
| +7% | +$30.5K | ﹤0.01% | 2655 |
|
|
2018
Q2 | $575K | Buy |
28,800
+5,200
| +22% | +$104K | ﹤0.01% | 2554 |
|
|
2018
Q1 | $413K | Buy |
23,600
+4,100
| +21% | +$71.8K | ﹤0.01% | 2566 |
|
|
2017
Q4 | $481K | Hold |
19,500
| – | – | ﹤0.01% | 2533 |
|
|
2017
Q3 | $503K | Hold |
19,500
| – | – | ﹤0.01% | 2557 |
|
|
2017
Q2 | $529K | Buy |
19,500
+10,200
| +110% | +$277K | ﹤0.01% | 2569 |
|
|
2017
Q1 | $277K | Buy |
9,300
+1,800
| +24% | +$53.6K | ﹤0.01% | 2725 |
|
|
2016
Q4 | $204K | Buy |
+7,500
| New | +$204K | ﹤0.01% | 2860 |
|